Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammation × Neoadjuvant Therapy × Breast × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 84 Inflammatory Breast Neoplasms 7 Carcinoma, Intraductal, Noninfiltrating 7 Breast Neoplasms, Male 5 Breast Carcinoma In Situ 5 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 3 Neoplasms 3 Locally Advanced Breast Cancer 2 Breast Cancer Patients 2 Pathologic Complete Response 1 Neovascularization, Pathologic 1 Margins of Excision 1 Inflammation 1 Infertility 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Colorectal Neoplasms 1 Carcinoma, Lobular 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anxiety Disorders 1

Interventions

palbociclib 2 Ketorolac 2 dapagliflozin 1 Tablets 1 Surgical Procedures, Operative 1 Sulindac 1 Specimen Handling 1 Rivaroxaban 1 Resistance Training 1 Radiotherapy, Conformal 1 Pregabalin 1 Plastic Surgery Procedures 1 Omeprazole 1 Neoadjuvant Therapy 1 Mastectomy 1 Massage 1 Losartan 1 Ibuprofen 1 Fish Oils 1 Exercise 1 Cognitive Behavioral Therapy 1 Bevacizumab 1 Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06447532 2025-03-12

INFLAMMATE

Federal University of São Paulo

Enrolling by invitation

Breast Neoplasms, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡